Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Denham

Showing results (141-150 of 275) with videos related to

Pageof 28
Sort By:
Australasian Radiology|May 1, 1993
Low dose rate teletherapy and tumour responseC S Hamilton, S A Simpson, S Ferguson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2015
Dosimetry, clinical factors and medication intake influencing urinary symptoms after prostate radiotherapy: An analysis of data from the RADAR prostate radiotherapy trialNoorazrul Yahya, Martin A Ebert, Max Bulsara, et al.
Archives of Surgery (Chicago, Ill. : 1960)|November 21, 1997
Cytokine activation through sublethal hemorrhage is protective against early lethal endotoxic challengeE E Zervos, J G Norman, D W Denham, et al.
International Journal of Cancer|November 25, 2000
Pilot study of high-frequency ultrasound to assess cutaneous oedema in the conservatively managed breastC Wratten, J Kilmurray, S Wright, et al.
Australasian Radiology|April 13, 2000
Decision-making models in the analysis of portal films: a clinical pilot studyA See, T Kron, J Johansen, et al.
The Medical Journal of Australia|June 5, 1989
The price of a false-negative result of mammography and an overenthusiastic lay pressS G Cooper, J W Denham, C S Hamilton, et al.
Journal of Medical Imaging and Radiation Oncology|January 15, 2014
Serum procollagen 1 amino-terminal propeptide (P1NP) in prostate cancer: pitfalls of its use as an early surrogate marker for bone metastasisEka Moseshvili, David J Joseph, Nigel A Spry, et al.
Annals of Surgery|June 24, 1998
Transient human gene therapy: a novel cytokine regulatory strategy for experimental pancreatitisW Denham, D Denham, J Yang, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2017
Modeling Urinary Dysfunction After External Beam Radiation Therapy of the Prostate Using Bladder Dose-Surface Maps: Evidence of Spatially Variable Response of the Bladder SurfaceNoorazrul Yahya, Martin A Ebert, Michael J House, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 19, 2015
Urinary symptoms following external beam radiotherapy of the prostate: Dose-symptom correlates with multiple-event and event-count modelsNoorazrul Yahya, Martin A Ebert, Max Bulsara, et al.
Pageof 28

Showing results (141-150 of 275) with videos related to

Sort By:
Pageof 28
Australasian Radiology|May 1, 1993
Low dose rate teletherapy and tumour responseC S Hamilton, S A Simpson, S Ferguson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2015
Dosimetry, clinical factors and medication intake influencing urinary symptoms after prostate radiotherapy: An analysis of data from the RADAR prostate radiotherapy trialNoorazrul Yahya, Martin A Ebert, Max Bulsara, et al.
Archives of Surgery (Chicago, Ill. : 1960)|November 21, 1997
Cytokine activation through sublethal hemorrhage is protective against early lethal endotoxic challengeE E Zervos, J G Norman, D W Denham, et al.
International Journal of Cancer|November 25, 2000
Pilot study of high-frequency ultrasound to assess cutaneous oedema in the conservatively managed breastC Wratten, J Kilmurray, S Wright, et al.
Australasian Radiology|April 13, 2000
Decision-making models in the analysis of portal films: a clinical pilot studyA See, T Kron, J Johansen, et al.
The Medical Journal of Australia|June 5, 1989
The price of a false-negative result of mammography and an overenthusiastic lay pressS G Cooper, J W Denham, C S Hamilton, et al.
Journal of Medical Imaging and Radiation Oncology|January 15, 2014
Serum procollagen 1 amino-terminal propeptide (P1NP) in prostate cancer: pitfalls of its use as an early surrogate marker for bone metastasisEka Moseshvili, David J Joseph, Nigel A Spry, et al.
Annals of Surgery|June 24, 1998
Transient human gene therapy: a novel cytokine regulatory strategy for experimental pancreatitisW Denham, D Denham, J Yang, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2017
Modeling Urinary Dysfunction After External Beam Radiation Therapy of the Prostate Using Bladder Dose-Surface Maps: Evidence of Spatially Variable Response of the Bladder SurfaceNoorazrul Yahya, Martin A Ebert, Michael J House, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 19, 2015
Urinary symptoms following external beam radiotherapy of the prostate: Dose-symptom correlates with multiple-event and event-count modelsNoorazrul Yahya, Martin A Ebert, Max Bulsara, et al.
Pageof 28